Byrd is overfunding on Seedrs

Posted by 

SETsquared Bristol

SETsquared Bristol member, Byrd, a technology startup for runners, is currently overfunding on the equity crowdfunding platform Seedrs.

Byrd’s unique EQAI coach builds the right run at the right time for each individual using over 1 billion variables. The investment from the raise will enable Byrd to launch in September 2021.

Edd Baldry, CEO said: “We’ve been blown away by the speed at which investors have been aligning with our mission to keep people running. We were overfunding in little over 24 hours and are now over 150% of our minimum target. The investment will allow us to launch Byrd later this year.”

Byrd’s mission is to keep people running by building a coaching experience around each individual. Paul Dawson, of i2Pd and previously VP of Health + Beauty at Dyson, was an early investor and said: “Byrd’s unique EQAI is incredibly exciting. Their combination of emotional intelligence with artificial intelligence feels like the future of health and fitness technology.”

Byrd has been part of the SETsquared partnership since February 2020. The members of the Byrd team have been an active part of the Bristol and Bath design and technology community over the last five years coming from Dyson, Potato London, Torchbox and Sunhouse Creative.

Anyone can invest in Byrd and own a piece of the company. Byrd deliberately picked Seedrs as a platform to enable investments from as little as £12. More information is at www.seedrs.com/byrd or at byrd.run.

 

Discover more of the companies SETsquared incubate here and sign up to the monthly SETsquared newsletter to keep up with news, events, opportunities and more.

Recent News, Blogs and Stories

DRIFT Energy’s fleet of net positive ships (MVY – Most Valuable Yachts) - credit DRIFT Energy

DRIFT Energy plans first green hydrogen-producing vessel build following seed investment

DRIFT Energy has announced the close of its seed funding round led by Octopus Ventures, and with support from Blue Action Accelerator, the company has secured a total of £4.65...
FluoretiQ founders smiling with technology on PC

FluoretiQ patent granted to enable fast and accurate antibiotic testing

Bristol-based biotech company, FluoretiQ, who is developing fast and accurate point-of-care testing for Urinary Tract Infections (UTIs) and Sexually Transmitted Diseases (STDs), has taken a significant step forward after having...
GenomeKey blood sample in lab

GenomeKey awarded $11.4M to transform sepsis diagnosis and treatment

GenomeKey has been awarded a major grant from Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) to build a functioning, automated prototype of their desktop diagnostic device. The Bristol-based company joined our...

SUCCESS IS THE GOAL

Fast track your technology business